mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.2 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.2 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.2 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.2 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |